期刊文献+

鼻咽上皮细胞癌变与DNA甲基化特征的相关性研究 被引量:2

Study on the correlation of nasopharyngeal epithelium canceration with DNA methylation features
下载PDF
导出
摘要 目的探讨鼻咽上皮细胞癌变前后DNA甲基化特征。方法 6例鼻咽癌患者作为研究对象(包括鼻咽癌变前后自身对照标本3例),5例鼻咽炎患者作为对照,获取鼻咽组织标本,常规抽提DNA,染色质免疫共沉淀联合芯片技术检测全基因组DNA甲基化状况。结果鼻咽上皮细胞癌变后,CpG岛及启动子区基因发生明显甲基化。癌变组织CpG岛甲基化峰为3258±358个,鼻咽炎组织CpG岛甲基化峰为1974±710个,t=22.32,P<0.001;癌变组织启动子区甲基化基因为1307±484个,鼻咽炎组织启动子区甲基化基因为758±363个,t=6.6,P<0.01。这些甲基化基因涉及抑癌基因、细胞信号传导通路、细胞代谢活性等多个途径。结论 DNA甲基化参与了鼻咽上皮细胞癌变过程。 Objective To investigate the correlation of nasopharyngeal epithelium canceration with DNA methylation features based on an experimental study on clinical samples. Methods Included in this study were 6 patients with nasopharyngeal carcinoma (NPC), including 3 cases with their nasopharyngeal samples taken before canceration and after NPC developed, and 5 cases with nasopharyngitis as controls. Their nasopharyngeal tissue samples taken were routinely prepared by the procedures of paraffin imbedding and DNA was extracted from thick sections of paraffin block. Then, extracted DNA was broken by ultrasound procedure into fragments with a longth about 200 to 500 bp, and DNA-chromatin immune coprecipiUtion joint chip technology was utilized to test the whole genome DNA methylation sUtus. Results Methylation level in CpG islands and promoter region gene was significantly higher in the tissue samples of nasopharyngeal carcinoma (3258±358 methylation peaks) than that of nasopharyngitis (1974±710 methylation peaks) (t=22.32, p〈0.001);. It was also the same situation for methylation level in the region of promoter, with very higher methylation peaks in nasopharyngeal carcinoma tissues (1307±484) than that in the tissue samples of nasopharyngitis (758±363) (t=-6.6, p〈0.01). These genes with much higher methylation level involved those of turnor suppressor gene, signal transduction path way, cellular metabolism and some other aspects. Conclusions DNA methylation may be involved in the carcinogenesis of nasopharyngeal epithela
出处 《中国中西医结合耳鼻咽喉科杂志》 2013年第1期22-26,共5页 Chinese Journal of Otorhinolaryngology in Integrative Medicine
基金 国家自然科学基金(81072847) 中山市科技局课题(20122A014)
关键词 鼻咽癌 DNA甲基化 癌变机理 Nasopharyngeal carcinoma DNA methylation Carcinogenesis
  • 相关文献

参考文献3

二级参考文献32

  • 1Costa FF, Verbisck NV, Salim AC, Ierardi DF, Pires LC, Sasahara RM, Sogayar MC, Zanata SM, Mackay A, O'Hare M, Soares F, Simpson AJ, Camargo AA. Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors. Oncogene 2004; 23:1481-2488.
  • 2Seals DF, Courtneidge SA. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev 2003; 17:7-30.
  • 3O'Shea C, McKie N, Buggy Y, Duggan C, Hill AD, McDermott E, O'Higgins N, Duffy MJ. Expression of ADAM-9 mRNA and protein in human breast cancer. Int J Cancer 2003; 105:754-761.
  • 4McCulloch DR, Akl P, Samaratunga H, Herington AC, Odorico DM. Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP. Clin Cancer Res 2004; 10:314-323.
  • 5Shintani Y, Higashiyama S, Ohta M, Hirabayashi H, Yamamoto S, Yoshimasu T, Matsuda H, Matsuura N. Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis. Cancer Res 2004; 64:4190-4196.
  • 6Kodama T, Ikeda E, Okada A, Ohtsuka T, Shimoda M, Shiomi T, Yoshida K, Nakada M, Ohuchi E, Okada Y. ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor. Am J Pathol 2004; 165:1743-1753.
  • 7Carl-McGrath S, Lendeckel U, Ebert M, Roessner A, Rocken C. The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer. Int J Onco12005; 26:17-24.
  • 8Hagihara A, Miyamoto K, Furuta J, Hiraoka N, Wakazono K, Seki S, Fukushima S, Tsao MS, Sugimura T, Ushijima T. Identification of 27 5' CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers. Oncogene 2004; 23: 8705-8710.
  • 9Calmon MF, Colombo J, Carvalho F, Souza FP, Filho JF, Fukuyama EE, Camargo AA, Caballero OL, Tajara EH, Cordeiro JA, Rahal P. Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer. Cancer Genet Cytogenet 2007; 173:31-37.
  • 10Takada H, Imoto I, Tsuda H, Nakanishi Y, Ichikura T, Mochizuki H, Mitsufuji S, Hosoda F, Hirohashi S, Ohki M, Inazawa J. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation. Oncogene 2005; 24: 8051-8060.

共引文献13

同被引文献11

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部